Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004738-90Phase 3Active
Phase 3, randomised trial of PRGF-Endoret in knee osteoarthritis (OA), sponsored by Arthroscopic Surgery Unit. Primary endpoint: Clinically significant pain improvement (KOOS pain subscale). Started Jan 2016; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004738-90.